Totally agree, Nader already said there are others looking at the Nash data already. NASH is a billion dollar deal, that means only BP can be interested. I don’t think it is a stretch for BP to want the whole enchilada. Why have a 12 year hiv deal based on sales revenue complicating a much bigger deal? The one thing for sure is there is a lot of interest and there is nothing but stellar data that is only getting better. We were a late stage hiv drug, now we are a middle stage everything drug. Most of these buy out deals occur in the early to middle stages, once a company gets to late stage it seems like the opportunities have all passed. Nash and cancer have revived the sizzle on the steak.